Israel Acqsns Financials
This page shows Israel Acqsns (ISRLF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Israel Acqsns passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Israel Acqsns generates $1.19 in operating cash flow ($3.3M OCF vs $2.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Israel Acqsns reported $2.8M in net income in fiscal year 2024. This represents a decrease of 53.6% from the prior year.
Cash & Balance Sheet
Israel Acqsns held $21K in cash against $0 in long-term debt as of fiscal year 2024.
Margins & Returns
Capital Allocation
Israel Acqsns spent $75.9M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 15476.7% from the prior year.
ISRLF Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$281K+19.5% | -$349K-24.1% | -$281K | N/A | -$234K+20.2% | -$294K+53.5% | -$632K | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$180K+24.2% | -$238K-457.3% | $67K | N/A | $811K+9.7% | $739K+28.3% | $576K | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ISRLF Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.9M+2.4% | $9.7M+1.9% | $9.5M-88.5% | $82.6M+1.3% | $81.6M+1.4% | $80.5M+1.1% | $79.6M-48.5% | $154.5M |
| Current Assets | $9.9M+2.4% | $9.7M+1.9% | $9.5M-88.5% | $82.6M+1.3% | $81.6M+1.4% | $80.5M+1.1% | $79.6M-48.5% | $154.5M |
| Cash & Equivalents | $64K+11.4% | $57K+110.6% | $27K+27.9% | $21K-20.4% | $27K-60.1% | $67K-79.0% | $318K-52.6% | $672K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $17.8M+3.4% | $17.2M+3.6% | $16.6M-81.5% | $89.5M+1.7% | $88.0M+1.7% | $86.5M+1.5% | $85.2M-46.5% | $159.4M |
| Current Liabilities | $8.0M+5.4% | $7.6M+5.9% | $7.2M+4.7% | $6.9M+5.7% | $6.5M+4.9% | $6.2M+2.1% | $6.1M+7.3% | $5.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$7.9M-4.8% | -$7.5M-5.9% | -$7.1M-3.7% | -$6.9M-6.2% | -$6.5M-6.3% | -$6.1M-7.9% | -$5.6M-16.0% | -$4.9M |
| Retained Earnings | -$7.9M-4.8% | -$7.5M-5.9% | -$7.1M-3.7% | -$6.9M-6.2% | -$6.5M-6.3% | -$6.1M-7.9% | -$5.6M-16.0% | -$4.9M |
ISRLF Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$103K-75.8% | -$59K+56.3% | -$134K-115.5% | $865K+1.1% | $855K+9.7% | $780K-8.1% | $849K+181.0% | $302K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$184K-1.1% | -$182K-100.2% | $73.2M+6785.6% | -$1.1M+8.4% | -$1.2M-1.2% | -$1.2M-101.6% | $74.6M+17017.6% | -$441K |
| Financing Cash Flow | $294K+8.5% | $271K+100.4% | -$73.1M-32577.9% | $225K-25.0% | $300K+100.0% | $150K+100.2% | -$75.8M | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0 | $0-100.0% | $73.5M | $0 | $0 | $0-100.0% | $75.9M | N/A |
ISRLF Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -1.8%+0.6pp | -2.5%-3.2pp | 0.7% | N/A | 1.0%+0.1pp | 0.9%+0.2pp | 0.7% | N/A |
| Current Ratio | 1.23-0.0 | 1.27-0.0 | 1.32-10.7 | 12.01-0.5 | 12.53-0.4 | 12.96-0.1 | 13.09-14.2 | 27.26 |
| Debt-to-Equity | -2.25+0.0 | -2.28+0.0 | -2.33+10.7 | -13.06+0.6 | -13.64+0.6 | -14.25+0.9 | -15.14+17.7 | -32.85 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$6.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Frequently Asked Questions
Is Israel Acqsns profitable?
Yes, Israel Acqsns (ISRLF) reported a net income of $2.8M in fiscal year 2024.
What is Israel Acqsns's operating cash flow?
Israel Acqsns (ISRLF) generated $3.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Israel Acqsns's total assets?
Israel Acqsns (ISRLF) had $82.6M in total assets as of fiscal year 2024, including both current and long-term assets.
What is Israel Acqsns's current ratio?
Israel Acqsns (ISRLF) had a current ratio of 12.01 as of fiscal year 2024, which is generally considered healthy.
What is Israel Acqsns's debt-to-equity ratio?
Israel Acqsns (ISRLF) had a debt-to-equity ratio of -13.06 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Israel Acqsns's return on assets (ROA)?
Israel Acqsns (ISRLF) had a return on assets of 3.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Why is Israel Acqsns's debt-to-equity ratio negative or unusual?
Israel Acqsns (ISRLF) has negative shareholder equity of -$6.9M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Israel Acqsns's Piotroski F-Score?
Israel Acqsns (ISRLF) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Israel Acqsns's earnings high quality?
Israel Acqsns (ISRLF) has an earnings quality ratio of 1.19x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.